Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,173 | 70,691,416 | -2.74% | -2.48% | -0.65% | 4.75% | 24.86% | 14.18% |
| Healthcare | HEALTHCARE | Sector | 1,168 | 6,660,528 | -1.71% | -1.81% | 2.36% | 7.17% | 9.02% | -2.27% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 597 | 3,403,724 | -1.38% | -1.00% | 5.31% | 9.83% | 15.11% | 1.11% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 282 | 1,340,626 | -2.09% | -0.66% | 7.46% | 8.26% | 7.48% | -2.57% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 105,045 | -2.34% | -2.05% | 3.50% | 13.65% | 25.20% | -7.00% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 1,331 | -2.40% | 2.52% | 50.62% | 94.42% | 291.97% | 144.00% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 1,121 | -2.74% | -2.06% | 35.11% | 2.64% | 79.09% | -15.51% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 1,652 | 0.97% | 18.11% | 26.42% | 156.94% | 330.06% | 152.64% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,788 | -3.73% | 5.31% | 23.93% | 1.81% | 40.93% | 42.10% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 2,160 | -4.41% | -2.34% | 23.45% | 21.42% | -56.67% | -81.26% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 895 | -5.52% | -5.97% | 22.38% | 46.34% | 117.50% | 124.95% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 541 | -2.43% | 1.31% | 19.22% | 61.58% | -1.66% | -38.83% |
| REGENXBIO, Inc. | RGNX:USARGNX:USA | Stock | 1 | 550 | -10.27% | 4.70% | 15.07% | 32.52% | 85.40% | 18.18% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 967 | -0.90% | -7.15% | 14.22% | 84.28% | 186.18% | 35.97% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 5,151 | -0.54% | 0.48% | 12.63% | 8.18% | 15.59% | 17.37% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,671 | -8.30% | -0.06% | 12.30% | 19.16% | -10.33% | -69.18% |
| ATAI Life Sciences NV | ATAI:USAATAI:USA | Stock | 1 | 1,082 | -6.42% | -2.49% | 10.87% | 92.45% | 295.35% | 367.89% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 5,257 | 0.33% | 1.32% | 8.65% | 38.70% | 54.09% | 65.82% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,606 | -4.29% | 7.58% | 6.64% | 69.69% | 99.57% | -56.12% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 3,050 | -3.97% | 0.08% | 6.50% | 25.92% | 26.24% | 0.56% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 8,212 | -1.97% | -2.90% | 5.43% | 20.60% | 34.76% | 26.19% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,750 | -1.03% | 1.34% | 5.02% | 46.23% | 54.72% | 51.33% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,239 | -4.95% | -0.32% | 3.71% | 8.47% | 21.02% | -42.04% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 91 | 105,045 | -2.34% | -2.05% | 3.50% | 13.65% | 25.20% | -7.00% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,592 | -5.86% | -3.45% | 3.00% | 12.93% | 32.31% | -50.18% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 781 | -4.48% | -3.89% | 0.88% | -21.26% | 39.89% | 91.34% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,492 | -2.21% | -2.30% | 0.54% | -2.82% | -7.66% | 1.95% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,196 | 93,743,934 | -2.70% | -2.42% | -0.43% | 5.25% | 23.00% | 14.52% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 6,063 | -0.66% | 1.17% | -1.02% | 10.52% | 24.12% | 45.69% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 21,487 | -2.03% | -8.32% | -1.53% | 14.96% | 27.26% | -21.10% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 792 | -2.63% | -6.93% | -3.24% | -14.72% | 4.63% | 80.70% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 13,526 | -1.33% | -0.29% | -4.85% | 4.11% | 50.36% | 22.41% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 1,109 | -0.83% | -1.37% | -8.98% | 80.99% | 95.68% | 22.63% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,382 | -2.76% | -7.98% | -17.11% | -8.86% | 37.59% | 37.49% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,527 | -0.90% | -2.71% | -20.59% | -23.82% | -9.02% | -21.01% |
* Colors indicate performance relative to the benchmark.